SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Celgene-CELG
CELG 108.240.0%Nov 22 4:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: tuck who wrote (745)3/27/2008 4:58:03 PM
From: idos  Read Replies (1) of 804
 
You're right, Thalomid's exclusivity is not protected by COM patents (it has been in the public domain for a number of years) but rather by patents around the S.T.E.P.S. program governing its use, administration and post-market surveillance. Barr needs to design its own patient monitoring system that avoids the claims in the key '501 patent of T. The litigation is in its very early discovery phase and there is no trial date set. I think it will be a bit longer than next fall.

Seems that their PDFs require Adobe 8.1.2.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News